RKDA
Arcadia Biosciences, Inc.
NASDAQ · Basic Materials · Agricultural Inputs · US
$0.47
+0.23%Aug 10, 2026, 00:00 UTC
Arcadia Biosciences received a notice from NASDAQ on August 4, 2026, stating that the company no longer complies with the minimum bid price requirement under Rule 5550(a)(2), and has until February 1, 2027, to regain compliance.
Jul 2, 2026, 00:00 UTC
Thomas J. Schaefer was promoted to Chief Executive Officer of Arcadia Biosciences, Inc. effective July 3, 2024.
Jul 2, 2026, 00:00 UTC
Mark Kawakami resigned as Chief Financial Officer of Arcadia Biosciences, Inc. effective September 12, 2025.
Jun 15, 2026, 00:00 UTC
Arcadia Biosciences, Inc. signed a $4 million at-the-market private placement of pre-funded warrants and investment options with an accredited institutional investor on June 12, 2026.
Jun 12, 2026, 00:00 UTC
Arcadia Biosciences announced a $4 million private placement of common stock and preferred investment options priced at-the-market under Nasdaq rules.